View Document Preview and Link Document Date: 2014-09-12 18:21:41 Open Document File Size: 410,37 KB Share Result on Facebook
City Denver / San Fransisco / Atlanta / Vancouver / Miami Beach / Toronto / Winnipeg / Boston / Chicago / / Company Database Research Group / Cox / Zelenitsky SA. / Can J Hosp Pharm / / Event FDA Phase / / Facility Hospital Pharmacists Research Grant Program / Hospital Pharmacists / / IndustryTerm vancomycin dosing protocol / reused medical devices / healthcare / / MedicalCondition Pseudomonas / vancomycinresistant S. aureus / vancomycin-intermediate S.aureus / ventilator-associated pneumonia / Enterobacteriaceae bloodstream infection / nd enterbacteriaceae bloodstream infections / heteroresistant vancomycin-intermediate S. aureus / Pathogens Causing Infections / th Enterbacteriaceae Bloodstream Infections / difficile infection / Bloodstream Infections / aeruginosa causing infections / Septic Shock / Q fever endocarditis / Infection / blastomycosis / Infections / influenza / / MedicalTreatment antibiotics / hemodialysis / Chemotherapy / / Organization Congress / Canadian Society / International Congress / American Society / Infectious Diseases Society of America / Intensive Care Unit / International Criminal Court / Canadian Society of Clinical Pharmacists / Canadian Antimicrobial Resistance Alliance / Society of Critical Care Medicine / Canadian Society of Hospital Pharmacists / / Person B. Ann Pharmacother / / Product Ceftazidime / Piperacillin / Acetaminophen / Appropriate Antibiotic / Linezolid / gentamicin / doxycycline / IV / ciprofloxacin / tobramycin / Hemodialysis Patients / / ProvinceOrState Illinois / / PublishedMedium Antimicrobial Agents and Chemotherapy / Critical Care Medicine / the Recent Consensus Review / / RadioStation Nicasio AM / Noreddin AM / / Technology pharmacokinetics / Chemotherapy / pharmacodynamics / Simulation / vancomycin dosing protocol / / SocialTag 
Peer-Reviewed Publications 1. Zhanel GG, Chung P, Adam H, Zelenitsky S, Denisuik A, Schweizer F, Lagacé-Wiens PR, Rubinstein E, Gin AS, Walkty A, Hoban DJ, Lynch JP 3rd, Karlowsky JA. Ceftolozane/Tazobactam: A novel cep